THE INANIMATE THIRD: GOING BEYOND PSYCHODYNAMIC APPROACHES FOR REMOTE PSYCHOTHERAPY DURING THE COVID-19 PANDEMIC

Article Neurosciences

Perceived social support in the social distancing era: the association between circles of potential support and COVID-19 reactive psychopathology

Sari Goldstein Ferber et al.

Summary: The study found that perceived support in close relationships was negatively associated with the intensity of depression, anxiety, OCD, and PTSD. Larger rings of potential support, such as perceived belongingness to a community and trust in government, were also negatively related to anxiety and depression but positively associated with the intensity of OCD and PTSD.

ANXIETY STRESS AND COPING (2022)

Add to Collection

Article Developmental Biology

Early life stress and development of the endocannabinoid system: A bidirectional process in programming future coping

Sari Goldstein Ferber et al.

Summary: The endocannabinoid system plays a critical role in regulating anxiety-like behaviors in humans and animal models, with early life stress potentially impacting gene expression and leading to changes in the adolescent brain. It modulates the neuroendocrine and behavioral effects of stress, while being sensitive to stress exposure itself, potentially increasing vulnerability to adult psychopathology. Early life stress alters the ontogeny of the ECS and can result in bidirectional changes in tissue levels of specific endocannabinoids in brain regions like the amygdala and hippocampus.

DEVELOPMENTAL PSYCHOBIOLOGY (2021)

Add to Collection

Review Neurosciences

Targeting the Endocannabinoid System in Borderline Personality Disorder: Corticolimbic and Hypothalamic Perspectives

Sari G. Ferber et al.

Summary: Borderline Personality Disorder (BPD) is a chronic debilitating psychiatric disorder characterized by emotional instability, chaotic interpersonal relationships, and cognitive disturbances. Studies have shown compromised brain regions, the hypothalamus and the corticolimbic system, in BPD patients, with potential involvement of the endocannabinoid system (ECS) in symptom improvement.

CURRENT NEUROPHARMACOLOGY (2021)

Add to Collection

Review Psychiatry